The Efficacy of Intravenous versus Subcutaneous Recombinant Erythropoietin in Obese African-African Patients in a Southeast U.S. Dialysis Cohort
Éva Csongrádi(University of Debrecen), Tibor Fülöp(Medical University of South Carolina), Lajos Zsom(Egis Pharmaceuticals (Hungary)), Michael Shoemaker‐Moyle(University of Mississippi Medical Center), Mihály Tapolyai(Szent János Kórház), Zsolt Lengvárszky(Louisiana State University in Shreveport), Catherine Wells(National Cancer Institute)
Cited by 2
Related Papers
A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider
|Patient Preference and Adherence|2022|156
Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study
|Molecular Psychiatry|2014|129
Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer
|Cancer Research|2018|126
Defining Incident Chronic Kidney Disease in the Research Setting: The ARIC Study
|American Journal of Epidemiology|2009|119